These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 15249771)
21. [Psoriasis is more than just a skin disease. Patients should be monitored for cardiovascular risk factor]. Duvetorp A; Ljungberg A; Seifert O Lakartidningen; 2013 Oct 9-15; 110(41):1796-8. PubMed ID: 24187892 [No Abstract] [Full Text] [Related]
22. The extent and determinants of diabetes and cardiovascular disease comorbidity in South Africa - results from the South African National Health and Nutrition Examination Survey (SANHANES-1). Mutyambizi C; Chola L; Groot W; Pavlova M; Labadarios D; Hongoro C BMC Public Health; 2017 Sep; 17(1):745. PubMed ID: 28950847 [TBL] [Abstract][Full Text] [Related]
24. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program. Blonde L; Dempster J; Gallivan JM; Warren-Boulton E J Am Acad Nurse Pract; 2006 Nov; 18(11):524-33. PubMed ID: 17064330 [TBL] [Abstract][Full Text] [Related]
26. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study. Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384 [TBL] [Abstract][Full Text] [Related]
27. The impact of diabetes mellitus on cardiovascular disease in North Carolina. Bell RA; Huston S; Passaro K; Lengerich E N C Med J; 1998; 59(4):222-6. PubMed ID: 9682589 [No Abstract] [Full Text] [Related]
28. Arresting cardiovascular disease progression. Early treatment may counteract high risk. Ram CV; Vergne-Marini P Postgrad Med; 2004 Aug; 116(2):45-8. PubMed ID: 15323153 [TBL] [Abstract][Full Text] [Related]
29. Psoriasis: a skin disease associated with increased cardiovascular risk. González-Gay MA; González-Vela C; González-Juanatey C Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257 [TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus in Bahrain: an overview. Musaiger AO Diabet Med; 1992 Jul; 9(6):574-8. PubMed ID: 1643809 [TBL] [Abstract][Full Text] [Related]
31. Symposium: nutritional and metabolic diversity: understanding the basis of biologic variance in the obesity/diabetes/cardiovascular disease connection. Introduction. Tobin B; Miller G J Nutr; 2001 Feb; 131(2):333S-5S. PubMed ID: 11160556 [No Abstract] [Full Text] [Related]
32. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey. Salami JA; Valero-Elizondo J; Ogunmoroti O; Spatz ES; Rana JS; Virani SS; Blankstein R; Younus A; Arrieta A; Blaha MJ; Veledar E; Nasir K J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28600400 [TBL] [Abstract][Full Text] [Related]
33. Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor. Grover SA; Coupal L; Zowall H; Weiss TW; Alexander CM Am J Med; 2003 Aug; 115(2):122-8. PubMed ID: 12893398 [TBL] [Abstract][Full Text] [Related]
34. Prediabetes: Why Should We Care? Zand A; Ibrahim K; Patham B Methodist Debakey Cardiovasc J; 2018; 14(4):289-297. PubMed ID: 30788015 [TBL] [Abstract][Full Text] [Related]
35. Do primary health care nurses address cardiovascular risk in diabetes patients? Daly B; Kenealy T; Arroll B; Sheridan N; Scragg R Diabetes Res Clin Pract; 2014 Nov; 106(2):212-20. PubMed ID: 25271111 [TBL] [Abstract][Full Text] [Related]
36. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS). Feldman DI; Valero-Elizondo J; Salami JA; Rana JS; Ogunmoroti O; Osondu CU; Spatz ES; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K Atherosclerosis; 2017 Mar; 258():79-83. PubMed ID: 28214425 [TBL] [Abstract][Full Text] [Related]
37. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice]. Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Alvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Cammafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P; Hipertens Riesgo Vasc; 2017; 34(1):24-40. PubMed ID: 28017552 [TBL] [Abstract][Full Text] [Related]
38. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for theAmerican Cancer Society, the American Diabetes Association, and the American Heart Association. Eyre H; Kahn R; Robertson RM; CA Cancer J Clin; 2004; 54(4):190-207. PubMed ID: 15253917 [TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms of diabetic cardiovascular disease. Hupfeld CJ; Wong GA Prev Cardiol; 2002; 5(4):183-7. PubMed ID: 12417827 [TBL] [Abstract][Full Text] [Related]
40. Self-management education by group care reduces cardiovascular risk in patients with type 2 diabetes: analysis of the ROMEO clinical trial. Sicuro J; Charrier L; Berchialla P; Cavallo F; Merlo S; Mazzeo A; Porta M; Trento M; Diabetes Care; 2014 Sep; 37(9):e192-3. PubMed ID: 25147259 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]